Compare iShares China Large-Cap ETF (FXI) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Lam Research Corporation — how do they compare? iShares China Large-Cap ETF trades at $34.52, while Lam Research Corporation trades at $317.68 (market cap $419.48B). The key difference: Lam Research Corporation pays a 0.31% dividend while iShares China Large-Cap ETF pays none, and Lam Research Corporation is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| FXI | LRCX | |
|---|---|---|
52-Week High | $41.75 | $433.33 |
52-Week Low | $31.59 | $94.84 |
Market Cap | — | $419.48B |
Sector | — | Technology |
Enterprise Value | — | $418.46B |
Dividend Yield | — | 0.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI is currently trading at $34.545, up 2.29% with strong technical momentum indicated by bullish moving averages and ADX signals. The ETF benefits from China's accelerating AI and manufacturing sectors, with recent news highlighting a $295 billion AI infrastructure plan and robust export growth. However, RSI readings above 89 suggest the ETF is significantly overbought near-term.
The outlook remains positive given China's strategic investments in technology and manufacturing, though investors face risks from US-China trade tensions and potential profit-taking after recent gains. Wall Street sentiment is cautiously optimistic as institutional flows respond to China's economic initiatives.
Lam Research (LRCX) trades at $319.85, down 7.58% amid broader semiconductor sector volatility. The stock shows strong fundamentals with Q1 2026 EPS of $1.47 beating estimates by 8.1% and revenue growth accelerating to $18.44B in 2025. Technical indicators are neutral with support at $322 and resistance at $346, while analyst consensus remains bullish with a $393 price target representing 23% upside potential from current levels.
LRCX presents a compelling growth story driven by AI semiconductor demand, though elevated valuation ratios (P/E 63.4, P/S 19.6) and sector volatility pose risks. The company's strong profitability (30.9% net margin) and consistent earnings beats support the bullish case, but investors should monitor competitive pressures and cyclical semiconductor equipment spending trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
